Trueblue (TBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
3 Mar, 2026Executive summary
Announced second consecutive quarter of organic revenue growth and outlined plans to improve profitability, lower operating costs, and build a more agile organization over time.
Addressed ongoing proxy contest initiated by EHS Investments, emphasizing ongoing engagement and willingness to work constructively.
Forward-looking statements highlight expectations for margin improvement, free cash flow generation, and growth from digital investments, subject to various risks.
Voting matters and shareholder proposals
EHS Investments is pressing a proxy contest, with ongoing settlement discussions and public communications between parties.
Shareholders are encouraged to review the definitive proxy statement and accompanying BLUE proxy card for the 2026 annual meeting.
Board of directors and corporate governance
Recent board refreshment included appointing William Greenblatt and William Seward, both endorsed by the largest shareholder.
Two existing directors will step down at or before the 2026 annual meeting as part of ongoing board evolution.
Board refreshment process included interviews with EHS nominees, reflecting commitment to evolving board composition.
Latest events from Trueblue
- Revenue up 8% to $418M, but net loss widened on impairment; margin pressure persists.TBI
Q4 202518 Feb 2026 - Q2 revenue down 17% to $396M, net loss $105M, with cost cuts and digital focus amid uncertainty.TBI
Q2 20242 Feb 2026 - Digital innovation and market expansion drive growth and margin gains in a fragmented staffing sector.TBI
Sidoti September Small-Cap Virtual Conference20 Jan 2026 - Q3 revenue dropped 19.2% with a $59.1M goodwill impairment and strong cost controls.TBI
Q3 202416 Jan 2026 - Board refreshment and strategic initiatives position the company for long-term growth.TBI
Proxy Filing9 Jan 2026 - Board refreshment and strategic focus highlighted as proxy process begins for 2026.TBI
Proxy Filing9 Jan 2026 - Q4 revenue fell 22% but margin gains, cost cuts, and healthcare expansion support recovery.TBI
Q4 202424 Dec 2025 - Board appointments and refreshment aim to drive growth, oversight, and long-term value.TBI
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, executive pay, incentive plan, and auditor, with strong governance and ESG focus.TBI
Proxy Filing1 Dec 2025